Welcome to our dedicated page for Aspen Aerogels news (Ticker: $ASPN), a resource for investors and traders seeking the latest updates and insights on Aspen Aerogels stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Aspen Aerogels's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Aspen Aerogels's position in the market.
Aspen Aerogels, Inc. reported $94.5 million in company revenue with 37% gross profit margins and $12.9 million Adjusted EBITDA for Q1 2024. They raised their 2024 Adjusted EBITDA outlook by 83% and expect positive net income for the year. Recent business highlights include revenue growth, thermal barriers, operating income improvement, and awards received. The updated 2024 financial outlook shows significant growth in revenue, Adjusted EBITDA, net income, and earnings per share.
Aspen Aerogels, Inc. (NYSE: ASPN) received both the Automotive News PACE Award and the Innovation Partnership Award for its PyroThin C2C barrier platform used in electric vehicle battery safety. The company collaborated with General Motors to develop the solution, recognized for its industry-leading innovation and technology advancement. Aspen's PyroThin technology has revolutionized the automotive industry by improving EV safety, energy density, and cell health across North America, Europe, and Asia. With a rich history of customer collaboration and innovation, Aspen continues to push the boundaries of what is achievable in the industry.
